Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00720616|
Recruitment Status : Withdrawn
First Posted : July 23, 2008
Last Update Posted : February 20, 2013
Oregon Health and Science University
Information provided by (Responsible Party):
Kevin Yuen, Oregon Health and Science University
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Estimated Primary Completion Date :||October 2012|
|Estimated Study Completion Date :||December 2012|
Yuen K, Wareham N, Frystyk J, Hennings S, Mitchell J, Fryklund L, Dunger D. Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance. Eur J Endocrinol. 2004 Jul;151(1):39-45.